Skip to main content

Table 4 Association between UGT2B15, UGT2B17, UGT2B28 H-scores and pathological Gleason score

From: UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression

 

Pathological Gleason Score

 
 

2 – 6

3 + 4

(4 + 3) – 10

P-value

UGT2B15

   

0.55*

 Median

42.8

39.0

31.3

 

 Q1-Q3

28.8-61.9

21.5-65.9

24.5-50.5

 

  < Median

16 (41%)

48 (48%)

31 (61%)

0.15**

  ≥ Median

23 (59%)

52 (52%)

20 (39%)

 

UGT2B17

   

0.84*

 Median

72.4

78.5

78.2

 

 Q1-Q3

59.8-88.1

58.6-94.9

68.2-84.6

 

  < Median

22 (56%)

48 (48%)

25 (49%)

0.66**

  ≥ Median

17 (44%)

52 (52%)

26 (51%)

 

UGT2B28

   

0.89*

 Median

86.0

86.0

86.4

 

 Q1-Q3

58.4-102.9

63.6-109.3

74.1-102.2

 

  < Median

20 (51%)

50 (50%)

25 (49%)

0.98**

  ≥ Median

19 (49%)

50 (50%)

26 (51%)

 
  1. P-value calculated using *Kruskal-Wallis test or **chi-squared test